Twelve month prospective study of snakebite in a major teaching hospital in Mandalay, Myanmar; Myanmar Snakebite Project (MSP).

AKI Antivenom Coagulopathy Myanmar Prospective observational study Russell's viper Snakebite

Journal

Toxicon: X
ISSN: 2590-1710
Titre abrégé: Toxicon X
Pays: England
ID NLM: 101741983

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 14 03 2018
revised: 21 11 2018
accepted: 26 11 2018
entrez: 25 8 2020
pubmed: 7 12 2018
medline: 7 12 2018
Statut: epublish

Résumé

The Myanmar Snakebite Project is an Australian government (Department of Foreign Affairs and Trade) supported foreign aid project in collaboration with the Myanmar government with the aim of improving outcomes for snakebite patients in Myanmar. As part of the project a case record database was established to document prospective cases of snakebite presenting to Mandalay General Hospital, in Upper Myanmar. The study period was 12 months (1-2-2016 to 31-1-2017). Snake identity was based on a mixture of identified dead snakes brought with patients, doctor's clinical opinion and patient identification. 965 patients were enrolled during the 12 month period, of whom 948 were included for analysis. The male: female ratio was 1.58:1. Most cases involved bites to the lower limbs (82.5%) and adults involved in farm work, confirming snakebite as an occupational disease in this community. Motorised transport was by far the most common form of transport to health care and most patients sought care from the health system (87.7%), not traditional healers (11.5%) as their first point of contact. The officially promoted application of a pressure pad, bandage and immobilisation as first aid for snakebite was almost never used, while most patients used some form of tourniquet (92.0%). 85.4% of cases where a snake ID was listed were bitten by Russell's vipers. Russell's viper bites were responsible for all fatalities (9.8% of cases) and all cases of Acute Kidney Injury (AKI). For all cases, clinical features included local swelling (76.5%), local pain (62.6%), AKI (59.8%), incoagulable blood (57.9%), regional lymphadenopathy (39.8%), nausea/vomiting (40.4%), thrombocytopenia (53.6%), abdominal pain (28.8%), shock (11.8%), secondary infection (8.6%), panhypopituitarism (2.1%). AKI required renal replacement therapy (RRT) in 23.9% of cases, all ascribed to Russell's viper bite. Green pit viper bites were the next most common cause of bites (7.6%) and were associated with incoagulable blood (29%) and occasionally shock (5%) and local necrosis (3%), and in one case AKI not requiring RRT. In contrast to Russell's viper bites, green pit viper bite was most likely to occur in the home (49%). Some green pit viper patients were treated with Russell's viper antivenom (15%), presumably because they had incoagulable blood, although this antivenom is not effective against green pit viper envenoming. For the entire patient group, antivenom was given in 80.5% of cases. The most common indications were presence of coagulopathy/non-clotting blood (59.8%), local swelling (47.4%), oliguria/anuria (19.8%), heavy proteinuria (19.4%). A febrile reaction to antivenom was reported in 47.9% of cases, while anaphylaxis, occurred in 7.9% of cases.

Identifiants

pubmed: 32831343
doi: 10.1016/j.toxcx.2018.100002
pii: S2590-1710(18)30002-X
pii: 100002
pmc: PMC7286100
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100002

Informations de copyright

Crown Copyright © 2018 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):855-62
pubmed: 15115100
Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):678-81
pubmed: 8296375
Trans R Soc Trop Med Hyg. 1991 May-Jun;85(3):404-9
pubmed: 1835190
Toxicon. 1994 Sep;32(9):1045-50
pubmed: 7801340
Southeast Asian J Trop Med Public Health. 2000 Jun;31(2):346-8
pubmed: 11127337
Lancet. 1987 Oct 3;2(8562):763-7
pubmed: 2888987
Lancet. 1985 Dec 7;2(8467):1259-64
pubmed: 2866333
QJM. 2013 Oct;106(10):925-32
pubmed: 23674721
QJM. 2011 Feb;104(2):97-108
pubmed: 21115460
Q J Med. 1988 Sep;68(257):691-715
pubmed: 3256900
Bull World Health Organ. 1954;10(1):35-76
pubmed: 13150169
PLoS Negl Trop Dis. 2018 Feb 28;12(2):e0006299
pubmed: 29489824
Trans R Soc Trop Med Hyg. 2003 May-Jun;97(3):312-7
pubmed: 15228251
Eur J Biochem. 1992 Oct 15;209(2):635-41
pubmed: 1425670
Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):293-5
pubmed: 7660439
Thromb Haemost. 2017 Feb 28;117(3):500-507
pubmed: 28150853
Acta Trop. 1989 Jan;46(1):23-38
pubmed: 2566258
PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1018
pubmed: 21532748
Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):732-40
pubmed: 2533418

Auteurs

Julian White (J)

Toxinology Dept., Women's & Children's Hospital, North Adelaide, SA, 5006, Australia.
University of Adelaide, Adelaide, SA, 5000, Australia.

Sam Alfred (S)

Emergency Department, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.
University of Adelaide, Adelaide, SA, 5000, Australia.

David Bates (D)

Toxinology Dept., Women's & Children's Hospital, North Adelaide, SA, 5006, Australia.
University of Adelaide, Adelaide, SA, 5000, Australia.

Mohammad Afzal Mahmood (MA)

University of Adelaide, Adelaide, SA, 5000, Australia.

David Warrell (D)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Robert Cumming (R)

University of Sydney, Australia.

Khin Thida Thwin (KT)

Ministry of Health and Sport, Government of Myanmar, Myanmar.

Myat Myat Thein (MM)

Myanmar Snakebite Project Mandalay Office, Myanmar.

Myo Thant (M)

Myanmar Snakebite Project Mandalay Office, Myanmar.

Zaw Myo Naung (ZM)

Myanmar Snakebite Project Mandalay Office, Myanmar.

Ye Htet Naing (YH)

Myanmar Snakebite Project Mandalay Office, Myanmar.

Su Sint Sint San (SSS)

Myanmar Snakebite Project Mandalay Office, Myanmar.

Myat Thet Nwe (MT)

Myanmar Snakebite Project Mandalay Office, Myanmar.

Chen Au Peh (CA)

University of Adelaide, Adelaide, SA, 5000, Australia.
Department of Renal Medicine, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.

Classifications MeSH